Nestle creates line of targeted food for weight-loss drug users

Nestle is set to launch new products that it says are designed for people taking drugs such as Wegovy or Ozempic.

The world's biggest food company will sell a $5 (£3.92) line of frozen pizzas and protein-enriched pastas in the US.

Injections, sold under brand names such as Wegovy, Ozempic and Rybelsus, are intended for people with type 2 diabetes but people have admitted to taking the medication for off-label weight-loss purposes.

Products are set to hit supermarket shelves in October.